During the past decade, Hopital Saint Louis conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hopital Saint Louis" #1 sponsor was "GERCOR - Multidisciplinary Oncology Cooperative Group" with 6 trials, followed by "The Lymphoma Academic Research Organisation" with 3 trials sponsored, "Arthesys" with 1 trials sponsored, "Baim Institute for Clinical Research" with 1 trials sponsored and "Biotronik France" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hopital Saint Louis" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Centre Henri Becquerel" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Hopital Saint Louis" are "Pancreatic Cancer" (4 trials), "Colorectal Cancer" (2 trials), "Alveolar Hemorrhage" (1 trials), "Atrial Fibrillation" (1 trials) and "Atrial Flutter" (1 trials). Many other conditions were trialed in "Hopital Saint Louis" in a lesser frequency.

Most popular intervention types in "Hopital Saint Louis" are "Drug" (11 trials), "Device" (3 trials), "Radiation" (3 trials), "Procedure" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "gemcitabine hydrochloride" (3 trials), "oxaliplatin" (3 trials), "radiation therapy" (3 trials), "Rituximab" (2 trials) and "fluorouracil" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hopital Saint Louis" are 16 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hopital Saint Louis". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Hopital Saint Louis, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hopital Saint Louis, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".